Wegovy (semaglutide) is an injectable medication that is used with a reduced-calorie diet and increased exercise to help manage chronic weight in adults who are: Obese (body mass index = 30 kg/m2) OR Overweight (body mass index = 27 kg/m2) with at least one weight-related condition (e.g., high blood pressure, diabetes, high cholesterol) Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist
Melatonin for the treatment of sepsis: the scientific rationale
Patients whose weight loss stalls significantly before reaching goal weight deserve evaluation for medication addition
doi: 10.1111/dom.14202 7 HorowitzMArodaVRHanJHardyERaynerCK
Accessed October 29, 2023
If you consistently struggle to remember your injection day, ask your PlexusDx provider about shifting to a day that naturally fits your routinesuch as a specific meal day, a work schedule anchor, or a weekend pattern